IVF Preimplantation Test for Aneuploidy


PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment. Traditionally, PGT-A requires an invasive biopsy of a developing embryo for the removal and testing of a few cells.

PerkinElmer’s PG-Seq Rapid Non-Invasive PGT-A kit is specifically designed for this type of sample, which enables embryos to remain fully intact. The non-invasive test leverages PerkinElmer’s biopsy-based PG-Seq kit 2.0, to test the spent embryo culture media to accurately detect aneuploidies, as well as structural rearrangements, including unbalanced translocations and segmental errors.

PerkinElmer Inc.


This site uses Akismet to reduce spam. Learn how your comment data is processed.